Results 81 to 90 of about 15,790 (257)

Hyperthermic intraperitoneal chemotherapy for ovarian cancer: is there a role? [PDF]

Journal of Gynecologic Oncology, 2015
Epithelial ovarian cancer (EOC) remains a major killer of women despite the fact that, paradoxically, it has innate characteristics which should facilitate effective treatment: it begins, and frequently remains, confined within the peritoneal cavity for much of its natural history (apart, most notably) from retroperitoneal lymph node involvement, it is
openaire   +3 more sources

Cytoreductive Surgery and Hyperthermic İntraperitoneal Chemoterapy for Advance Gastric Cancer Associated Peritoneal Carcinomatosis Single Centre Unit for 10 Consecutive Patients

Haseki Tıp Bülteni, 2019
Aim:Hyperthermic intraperitoneal chemotherapy with cytoreductive surgery has a positive effect on survival in advanced abdominal cancers. We aimed to present our experience with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in ...
Özgül Düzgün, Sema Yüksekdağ, Murat Kalın, Şenol Çomoğlu, Semra Yanık, Ömer Faruk Özkan, Neşet Köksal   +6 more
doaj   +1 more source

Plasma‐activated media selectively induces apoptotic death via an orchestrated oxidative stress pathway in high‐grade serous ovarian cancer cells

Molecular Oncology, Volume 19, Issue 4, Page 1170-1187, April 2025.
High‐grade serous ovarian cancer (HGSOC) is the most common and aggressive type of ovarian cancer with urgent need for new treatment strategies. This study evaluates plasma‐activated media (PAM) as a novel treatment for HGSOC, showing its ability to selectively induce oxidative stress and apoptosis in HGSOC cell lines, patient ascites cells and primary
Lorena T. Davies, Raja Ganesen, John Toubia, Sung‐Ha Hong, Sushil Kumar KC, Martin K. Oehler, Carmela Ricciardelli, Endre J. Szili, Nirmal Robinson, Melissa R. Pitman   +9 more
wiley   +1 more source

Frailty screening in older patients undergoing elective colorectal surgery: Comparative study of seven screening instruments

Journal of the American Geriatrics Society, Volume 73, Issue 4, Page 1060-1072, April 2025.
Abstract Background Frailty screening instruments are increasingly studied as risk predictors for adverse postoperative outcomes. However, because of the lack of comparative research, it is unclear which screening instrument performs best. This study therefore compared the diagnostic accuracy of seven frailty screening instruments for adverse ...
Katleen Fagard, Lisa Geyskens, Björk Van den Bogaert, Sarah Willems, Johan Flamaing, Albert Wolthuis, Mieke Deschodt   +6 more
wiley   +1 more source

Lavage cytology diagnosed by immunostaining may be a poor prognostic factor in pathological stage III colorectal cancer

Annals of Gastroenterological Surgery, Volume 9, Issue 2, Page 271-280, March 2025.
Positive LCY as diagnosed by immunostaining may represent a poor prognostic factor for pathological stage III CRC. Abstract Aim To clarify the prognostic impact of positive lavage cytology diagnosed by immunostaining on long‐term outcomes following curative resection for pathological stage III colorectal cancer (CRC).
Akitoshi Nankaku, Yusuke Yamaoka, Akio Shiomi, Hiroyasu Kagawa, Shoichi Manabe, Takuma Oishi, Kiyoshi Tone, Akifumi Notsu, Yusuke Kinugasa   +8 more
wiley   +1 more source

Gloves Standards and Occupational Exposure to Antineoplastic Drugs in the European Context

Health Science Reports, Volume 8, Issue 3, March 2025.
ABSTRACT Background and Aims Over 12 million healthcare professionals in Europe are exposed to hazardous medicinal products, including antineoplastic drugs. Dermal route is recognized as the primary route of exposure to antineoplastic drugs, emphasizing the critical importance of skin protection provided by gloves, which necessitates a careful and ...
Guillaume Swierczynski, Mireille Canal‐Raffin, Ludovic Tuduri   +2 more
wiley   +1 more source

Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations

BMC Cancer, 2006
Background In selected patients with peritoneal carcinomatosis from colorectal cancer prognosis can be improved by hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery.
Dimmler A, Doerfer J, Pelz Joerg OW, Hohenberger W, Meyer T   +4 more
doaj   +1 more source

Implementation of a Multidisciplinary Enhanced Recovery After Surgery (ERAS) Program for Cytoreductive Surgery (CRS) With Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Journal of Surgical Oncology, Volume 131, Issue 3, Page 527-534, March 2025.
ABSTRACT Background and Objectives Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) can be associated with prolonged hospital stays. A novel Enhanced Recovery After Surgery (ERAS) based on ERAS Society guidelines was designed and implemented. The primary outcome was ERAS compliance.
Cecily Stockley, Antoine Bouchard‐Fortier, Jennifer Mateshaytis, Kadhim Taqi, Lloyd Mack, Gregg Nelson, Michael Chong, Melina Deban   +7 more
wiley   +1 more source

Successful Implementation of HITOC and HIPEC in the Management of Advanced Ovarian Carcinoma with Pleural and Peritoneal Carcinomatosis

Diagnostics
This case report details the application and outcomes of a novel therapeutic approach involving hyperthermic intraperitoneal chemotherapy (HIPEC) and hyperthermic intrathoracic chemotherapy (HITOC) in a single patient diagnosed with advanced ovarian ...
Bogdan Moldovan, Codin Theodor Saon, Iris-Iuliana Adam, Radu-Mihai Pisica, Vlad Teodor Silaghi, Vlad Untaru, Doly Stoica, Madalina Crisan, Andreea Popianas, Florentina Pescaru, Adriana Zolog, Liliana Vecerzan   +11 more
doaj   +1 more source

Impact of Pressurized Intraperitoneal Aerosol Chemotherapy on Quality of Life and Symptoms in Patients with Peritoneal Carcinomatosis: A Retrospective Cohort Study. [PDF]

, 2017
Background. Peritoneal cancer treatment aims to prolong survival, but preserving Quality of Life (QoL) under treatment is also a priority. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) is a novel minimally invasive repeatable treatment ...
Achtari, C., Demartines, N., Grass, F., Hübner, M., Kefleyesus, A., Montemurro, M., Romain, B., Teixeira Farinha, H.   +7 more
core   +4 more sources